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Abstract
Membrane targeting was investigated as a potential strategy to increase the fusogenic activity of an isolated fusion
peptide. This was achieved by coupling the fusogenic carboxy-terminal part of the b-amyloid peptide A b , amino acids
.  .29–40 , involved in Alzheimer’s disease, to a positively charged peptide PIP -binding peptide, PBP interacting2
 .specifically with a naturally occurring negatively charged phospholipid, phosphatidylinositol 4,5-bisphosphate PIP .2
 .  .Peptide-induced vesicle fusion was spectroscopically evidenced by: i mixing of membrane lipids, ii mixing of aqueous
 .vesicular contents, and iii an irreversible increase in vesicle size, at concentrations five to six times lower than the
 .  .A b 29–40 peptide. In contrast, at these concentrations the PBP-A b 29–40 peptide did not display any significant
activity on neutral vesicles, indicating that negatively charged phospholipids included as targets in the membranes, are
required to compensate for the lower hydrophobicity of this peptide. When the a-helical structure of the chimeric peptide
was induced by dissolving it in trifluoroethanol, an increase of the fusogenic potential of the peptide was observed,
supporting the hypothesis that the a-helical conformation of the peptide is crucial to trigger the lipid–peptide interaction.
The specificity of the interaction between PIP and the PBP moiety, was shown by the less efficient targeting of the2
chimeric peptide to membranes charged with phosphatidylserine. These data thus demonstrate that the specific properties of
 .both the A b 29–40 and the PBP peptide are conserved in the chimeric peptide, and that a synergetic effect is reached
through chemical linkage of these two fragments. q 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Membrane fusion is a widespread event, that plays
a crucial role in important physiological processes
such as endocytosis, exocytosis, secretion, fertiliza-
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w xtion or viral cell invasion 1–5 . A common feature
of the above processes is the active participation of
hydrophobic sequences within fusogenic proteins
w xtermed fusion peptides 6–9 . Fusion peptides have
been identified in several proteins, including viral
w x w xfusion proteins 10 , the b-amyloid peptide 11 , the
w x prion protein 8 and lipid-transfer proteins for re-
w x. w xview see Ref. 8 . Brasseur et al. 7,8 proposed that
these peptides act as oblique-orientated helices at the
lipid–water interface, as a result of an asymmetric
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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distribution of hydrophobic residues along the helical
motif. A tilted insertion of these peptides might
perturb the regular packing of the phospholipid acyl
chains and might in turn account for the fusogenic
activity andror the membrane toxicity of the above
w xproteins 1,9–14 .
Most fusion peptides described in the literature are
w x12- to 14-residue peptides 9–11,14 with only a
limited stability in an a-helical conformation, due to
their short length. The high hydrophobicity of these
peptides contributes to their strong self-association
tendency, and accounts for the high peptide concen-
trations required to induce membrane destabilization.
In the present study, we attempted to design a
more physiological fusogenic peptide, with increased
length and increased solubility in aqueous solvents
compared to natural fusogenic peptides. However,
increased solubility obtained by decreasing the over-
all hydrophobicity might result in a decreased affinity
of the fusogenic peptide for lipids. To circumvent this
problem, we used a strategy of chemically linking the
fusogenic peptide to another polar peptide ligand
which should target the fusogenic peptide to the
surface of the lipid bilayer. One possibility is target-
ing the fusogenic peptide to an integral membrane
protein, thus mimicking a receptor-mediated interac-
w xtion 13 . The strategy proposed here instead is the
coupling of the fusogenic peptide moiety to a peptide
that specifically recognizes target phospholipids,
which can be incorporated into the lipid vesicles used
to monitor fusion.
As model fusion peptide, we used the fusion pep-
tide identified in the C-terminal part of the b-amyloid
  .. w xpeptide at residues 29–40 A b 29–40 10 . The
A b peptide, a 39- to 42-residue peptide, is found in
an aggregated, poorly soluble form in extracellular
depositions in the brains and leptomeninges of pa-
w xtients with Alzheimer’s disease 15 . The mechanism
through which the A b peptide causes neuronal cell
death has not been elucidated yet. Results from sev-
eral studies suggest that the A b neurotoxicity might
be mediated through direct interactions between the
w xA b peptide and cellular membranes 16–18 . Pertur-
bation of cellular membranes by the carboxy-terminal
domain of A b is one of the mechanisms proposed to
w xaccount for the toxicity of the peptide 10 . Indeed,
 .the A b 29–40 peptide displays an asymmetric dis-
tribution of hydrophobic residues along the peptide
sequence and has significant membrane destabilizing
effects on lipid vesicles, causing vesicular fusion and
w xperturbation of membrane permeability 10 .
As a target peptide for the lipid membrane, we
selected a positively charged peptide interacting
specifically with phosphatidylinositol 4,5-bisphos-
 .phate PIP . This phospholipid carries multiple nega-2
tive charges and is present at less than 3 mol% in
natural membranes. This phospholipid plays a major
role in cellular signaling events linked to the organi-
w xzation of the cytoskeleton 19,20 . The PIP -binding2
peptide was further selected in order to mimic the
positively charged N-terminal domain of the b-
amyloid peptide. It has recently been shown that
 .  .membrane binding of the A b 1–40 and A b 1–42
peptides was maximal when these membranes con-
w xtained acidic phospholipids 21 . Moreover, phos-
phatidylinositol has been reported as the most effi-
cient acid phospholipid, able to enhance binding of
w xthe A b peptide to membranes 22 .
 .The PIP -binding peptide PBP used in this study2
was identified in fragmin, a member of the actin-bi-
nding proteins, involved in actin polymerization
w x23,24 . This sequence is homologous to the PIP -bi-2
w xnding segment of villin and gelsolin 25,26 . PIP2
efficiently competes with actin for binding to these
proteins, consistent with the role of PIP as a regula-2
tor of the actin network. Binding of the PBP peptide
to PIP is not only due to electrostatic interactions,2
since binding to other negatively charged phospho-
 .lipids such as phosphatidylserine PS is less efficient
w x23,27 . Specific interactions between phospholipids
and other peptides such as that between Penetratin,
identified in homeoproteins and phosphatidylserine
 . w xPS headgroups, were also reported 28 .
We therefore investigated the fusogenic properties
  ..of the synthetic composite peptide PBP-A b 29–40
on phospholipid vesicles, to which PIP was added at2
physiological concentrations. We report in this paper
that membrane targeting efficiently increases the fu-
 .sogenic properties of the A b 29–40 peptide, since
 . five to six times less PBP-A b 29–40 than A b 29–
.40 was required in order to observe the same extent
of fusion. Our data also suggest that due to the
increased solubility of the chimeric peptide in water,
the presence of target ligands on the membrane sur-
face is required to induce fusion. The specificity of
 .the interaction between the PBP-A b 29–40 peptide
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and PIP , was further characterized with respect to2
the specificity of the anionic lipid target. The speci-
ficity of the PBP–PIP interaction was preserved2
 .after chemical linkage of the PBP and A b 29–40
fragments. Taken together, these observations
demonstrate that the separate properties of each pep-
tide component are retained in the chimeric peptide.
These data further support the hypothesis that the
cytotoxicity of the b-amyloid peptide might be driven
by electrostatic interactions between positive charges
of the N-terminal domain of the amyloid peptide and
the net negative charges of cellular membranes. This
would be then followed by the insertion of the
 .A b 29–40 moiety into the lipid phase. The chimeric
peptide described here stresses the role of fusogenic
peptides in the membrane destabilization properties
of different proteins.
2. Materials and methods
2.1. Materials
 .L-a-Phosphatidylethanolamine PE from egg yolk,
 .L-a-phosphatidyl-L-serine PS from bovine brain, L-
 .a-phosphatidylcholine PC from egg yolk and phos-
 .phatidylinositol 4,5-bisphosphate PIP were pur-2
 .chased from Sigma. 1-Palmitoyl-2-pyrene 14 -phos-
 .phatidylcholine Pyr-PC was from Molecular Probes
 .Junction City, OR, USA . Reagents for peptide syn-
thesis and sequencing were purchased from Applied
 .Biosystems Foster City, USA . Trifluoroethanol
 .  .TFE and hexafluoro-2-propanol HFIP used for
sample preparation were of the highest grade from
X X   . 4Sigma. 2 ,7 - bis carboxymethyl aminomethyl fluo-
 . rescein calcein was from Molecular Probes Junc-
.tion City, OR, USA .
2.2. Synthesis and purification of peptides
  ..The amyloid peptide A b 29–40 , the PIP -bind-2
 . ing peptide PBP , and the chimeric peptide PBP-
 ..A b 29–40 were synthesized by the standard F-moc
solid-phase method, on an Applied Biosystems Model
431A peptide synthesizer. The peptide–resin conju-
gates were cleaved with trifluoroacetic acid, and the
peptides were precipitated twice with tributylmethyl
ether, and recovered by centrifugation at 2000=g
w x10 . The residue was dried for 2 h in a Speedvac
 .concentrator Savant Instr., Farmingdale, NY . The
 .peptides 20–40 mg were resuspended in aceto-
 .nitrilerwater 80r10, vrv to remove all scavengers
molecules, and the insoluble peptide was recovered
by centrifugation. The washing step was repeated 10
 .times with water. The PBP and PBP-A b 29–40
peptides were purified by reverse-phase HPLC on a
C18 column using a linear gradient of 0–80% aceto-
nitrile, with 0.007% trifluoroacetic acid. The purity
and correct sequences of all peptides were verified by
electrospray ionisation mass spectrometry using a
 .FisonsrVG Platform Manchester, UK mass spec-
trometer.
2.3. Circular dichroism measurements
The peptides were first dissolved in HFIP at 5
mgrml, then dried under a stream of nitrogen, and
further diluted at a final concentration of 0.1 mgrml
either in a 10 mM phosphate pH 7.5 buffer, in TFE,
 .or in buffer containing either 20 or 50% TFE vrv .
Circular dichroism spectra were obtained at 258C in a
Jasco 710 spectropolarimeter B a L Systems,
.Zoetermeer, Holland calibrated with 1 grl D-10-
w xcamphorsulfonic acid solution 29 . Nine spectra were
recorded 15 min after the peptides had been dis-
solved. The percentages of secondary structure were
estimated by curve-fitting on the entire ellipticity
curve between 184 and 260 nm according to the
variable selection procedure developed by Johnson
w x30 .
2.4. Preparation of ˝esicles
 .Phospholipids PC, PE, PS were dissolved in
chloroform at 10 mgrml. PIP was dissolved in pure2
water at 5 mgrml, by sonication in a water bath
sonicator for 10 min at room temperature, as de-
w xscribed elsewhere 31 . For the preparation of mixed
PCrPE and PCrPErPS vesicles, the corresponding
phospholipids were mixed in chloroform at the ap-
propriate molar ratios, PCrPE 2:1, PCrPErPS
 .20:10:5.4 18 mol% PS , and dried under a stream of
nitrogen. Dried lipid mixtures were resuspended in a
10 mM Tris–HCl pH 7.5 buffer, containing 150 mM
NaCl, 0.1 grl Na-EDTA and 1 mM NaN . Small3
 .unilamellar vesicles SUV were obtained by sonica-
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tion of the lipid suspensions with a Branson sonifier
 .Danbury, CT at 108C under a stream of nitrogen for
four times during 15 min. For the preparation of
vesicles consisting of PC, PE and PIP 1.5 and 32
. mol% PIP , PIP was added to the PCrPE 2:12 2
.MrM lipid suspension in buffer prior to sonication.
The SUV were labeled, when required, with 2.5
mol% Pyr-PC dissolved in chloroform together with
the other phospholipids. After sonication, the labeled
or unlabeled vesicles were applied to a Sepharose CL
4B column. SUV were separated from larger particles
eluting in the void volume of the column. In order to
obtain a homogenous preparation, only the top frac-
tions of the SUV elution peak were collected and
pooled. Phospholipid concentration was determined
 .by an enzymatic assay Biomerieux, France . Large´
 .unilamellar vesicles LUV were prepared from phos-
pholipids as follows. Dry lipids were hydrated in
buffer and dispersed by vortexing to produce large
multilamellar vesicles. The lipid suspension was
freeze-thawed five times, and then extruded 10 times
through two stacked 100 nm pore size polycarbonate
filters in a pressure extruder Lipex Biomembranes,
.Vancouver, Canada . The SUV and LUV prepara-
tions could be stored at 48C for at least 1 week,
without significant size change of the vesicles during
storage.
2.5. Lipid-mixing experiments
Fusion of pyrene-labeled vesicles together with
unlabeled vesicles, at a 1r4 wrw ratio, was followed
using a fluorescence probe dilution assay. The pyrene
excimerrmonomer intensity ratio was measured as a
function of time after addition of increasing quanti-
ties of the peptides, dissolved in either a 10 mM
Tris–HCl pH 7.5 buffer, containing 150 mM NaCl,
0.1 grl Na-EDTA and 1 mM NaN or in the same3
 .buffer containing 20, 50 or in 100% vrv TFE.
Fusion resulted in a decrease of the excimer intensity,
and a slight increase of the monomer fluorescence.
Emission spectra were obtained on an Aminco SPF
 .500 spectrofluorimeter MD, USA at 258C. The
 .pyrene excimerrmonomer ErM ratio was calcu-
lated from the excimer and monomer fluorescence
intensity at 475 and 398 nm, respectively, with an
excitation wavelength of 346 nm. The excitation and
emission band width were set at 2 and 5 nm, respec-
tively. Under these conditions, unlabeled vesicles in
the presence of the peptides gave no significant sig-
nal due to light scattering. All experiments were
performed at a phospholipid concentration of 42 mM,
in a 10 mM Tris–HCl pH 7.5 buffer, containing 150
mM NaCl, and 0.1 grl Na-EDTA. The final TFE
concentration in the reaction mixture was less than
 .5% v:v , and a correction was made for the effect of
the solvent on the excimerrmonomer ratio. The final
peptide concentrations were in the range of 1 to 40
mM.
2.6. Monitoring of ˝esicle size and lipid-bound pep-
tides by gel filtration
A total of 75 mM of labeled SUV were incubated
 .with 5 to 40 mM of PBP-A b 29–40 or PBP pep-
tides dissolved in 100% TFE, for 15 min at 258C in a
10 mM Tris–HCl pH 7.5 buffer, containing 150 mM
NaCl, 0.1 grl Na-EDTA and 1 mM NaN . The3
mixture was then applied to a Sepharose CL 4B
column in 0.05 M Tris–HCl buffer, pH 7.5, contain-
ing 150 mM NaCl and 1 mM NaN , in a FPLC3
 .system Pharmacia, Upsalla, Sweden . The fluores-
cence emission intensity of Pyr-PC was continuously
monitored, and the elution profile was compared to
that of vesicles in the absence of peptides. In a
 .parallel experiment, the PBP-A b 29–40 and PBP
peptides were detected by continuous monitoring of
the tyrosine fluorescence emission at 305 nm, as both
peptides contain one Tyr residue.
2.7. Core-mixing experiments
Vesicle fusion was also investigated by the core-
mixing assay developed by Kendall and MacDonald
w x32 . Lipid vesicles were prepared as described above,
except for the phospholipid mixture which was pre-
pared by hydrating 2 mg phospholipids in 1.5 ml of a
10 mM Tris–HCl pH 7.5 buffer containing 150 mM
NaCl and 1 mM NaN and containing 0.8 mM3
calcein together with 1 mM CoCl or 20 mM EDTA.2
Untrapped solutes were removed by two successive
elutions on a Sephadex G-25 column with a 10 mM
Tris–HCl pH 7.5 buffer, containing 150 mM NaCl,
and 1 mM NaN . Phospholipid concentration of the3
liposome suspensions was determined by an enzy-
 .matic assay BioMerieux, France . In a standard ex-´
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periment, calcein–Co2q, and EDTA-containing vesi-
cles were mixed at a 1:1 molar ratio 42 mM total
.phospholipids in a 10 mM Tris–HCl pH 7.5 buffer,
containing 150 mM NaCl and 1 mM NaN . Peptides3
from the concentrated stock solutions in 100% TFE
were added at different concentrations and the calcein
fluorescence was followed using an Aminco SPF 500
 .spectrofluorimeter MD, USA , with excitation and
emission wavelengths of 490 and 520 nm, respec-
tively, and with excitation and emission slits of 5 nm.
The maximum fluorescence yield was determined in
the presence of 0.5% Triton X-100 and 10 mM
EDTA. In some experiments, 0.4 mM CoCl chelated2
with 0.4 mM citrate was included in the reaction
mixture in order to monitor leakage of encapsulated
components. All experiments were performed under
constant stirring at 258C in the fluorimeter cuvette.
2.8. Leakage of liposomal content
Kinetics of the leakage of liposomal content into
the external buffer were monitored by measuring
w xrelease of the calcein trapped inside the vesicles 33 .
The vesicles were prepared as previously described,
except that dried lipids were rehydrated in a 10 mM
Tris–HCl pH 7.5 buffer, containing 150 mM NaCl,
0.1 grl Na-EDTA, 1 mM NaN and 40 mM calcein.3
At this concentration, fluorescence self-quenching oc-
curs. Uncapsulated calcein was removed by gel chro-
matography on Sephadex G-25 after elution with the
above buffer. The fluorescence of calcein encapsu-
lated at a self-quenching concentration in the lipo-
somes, increases under leakage from the vesicles.
The calcein fluorescence increase was followed upon
addition of the peptides dissolved in TFE to the
vesicle suspension. Measurements were performed on
an Aminco SPF 500 spectrofluorimeter, with excita-
tion and emission wavelengths at 490 and 520 nm,
respectively, and with excitation and emission slits of
5 nm. One hundred percent leakage was established
 .by lysis of the vesicles with 0.5% wrv Triton
X-100. The percentage of calcein release is calculated
  . .as: I t y I rI y I =100, where I s initial flu-0 tot 0 0
orescence, I s total fluorescence observed after ad-tot
 .dition of Triton X-100, and I t s fluorescence at
time t. In our experimental conditions, in the absence
of peptide, the spontaneous leakage rate was less than
1%r10 min. All experiments were with constant
stirring at 258C.
3. Results
3.1. Characteristics of the peptides
The sequence, mean hydrophobicity, and net charge
 .  .of the A b 29–40 , PBP and PBP-A b 29–40 pep-
tides are summarized in Table 1. The 12-residue long
 .A b 29–40 peptide is highly hydrophobic, with a
mean hydrophobicity close to that of a transmem-
w xbrane peptide on the Eisenberg’s scale 34 , and
devoid of charges. The 17-residue long PBP peptide
is a highly polar and charged peptide, containing six
ionized residues at physiological pH, a cluster of
three Lys and three Arg distributed along the se-
 .quence. The PBP-A b 29–40 peptide consists of the
Table 1
 .  .Characteristics of PBP-A b 29–40 , A b 29–40 and PBP peptides
a w xMean hydrophobicity was calculated using the Eisenberg consensus scale 34 .
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 .A b 29–40 peptide linked to the PBP peptide at the
N-terminal end. This composite peptide thus contains
29 residues, and combines the hydrophobic and hy-
 .drophilic properties of the A b 29–40 and PBP pep-
tides, respectively.
(3.2. Conformational properties of the PBP-Ab 29–
)40 and PBP peptides
Using circular dichroism spectroscopy, we first
examined the conformation of the peptides in a mix-
 .ture of TFE and buffer 10 mM phosphate, pH 7.5 as
a function of the TFE concentration. Fig. 1 displays
 .the CD spectra of the PBP-A b 29–40 and PBP
peptides in various solvent conditions. In an aqueous
buffer, the two peptides were totally soluble, and
displayed CD spectra typical of a random peptide
structure with a negative band at 197 nm and no
positive signal peak. Upon increasing the TFE con-
centration, a strong helix-promoting solvent, similar
spectral changes were observed for both peptides.
 .  .Fig. 1. Circular dichroism spectra of PBP-A b 29–40 A and
 .PBP B peptides. The peptides were dissolved at 0.1 mgrml, in
 .phosphate buffered water solution pH 7.5 — - — , 20% TFE
 .  .  ., 50% TFE - - - and 100% TFE — — — .
The intensity of the ellipticity minimum at 197 nm
decreased and became positive, while two negative
absorption peaks at 208 and 222 nm, characteristic of
an a-helical conformation, appeared at increasing
TFE concentrations. Comparison of the amplitudes of
 .the peak minima suggests that the PBP-A b 29–40
peptide has a higher propensity to form an a-helix
than the short PBP peptide. Indeed, the a-helical
 .content calculated for the PBP-A b 29–40 peptide
amounted to 41, 49 and 57% in 20, 50 and 100%
TFE, respectively, compared to 29, 37 and 47%
a-helix for PBP under the same conditions. When the
secondary structure is followed as a function of the
TFE concentration, an isodichroic point is observed
at 201 nm, suggesting a simple equilibrium between
helical and random coil structures for these two
peptides. Moreover, the absence of any significant
absorption at 218 nm suggests that b-sheet structures
do not contribute to the spectra.
3.3. Influence of the secondary structure of the pep-
tide upon its lipid mixing properties
We first investigated the influence of the sec-
 .ondary structure of the PBP-A b 29–40 peptide on
its fusogenic activity. For this purpose, the PBP-
 .A b 29–40 peptides dissolved either in buffer, in
100% TFE, or in buffer containing 20 and 50% TFE,
respectively, were added to PCrPErPIP SUV. The2
extent of intervesicular lipid mixing induced by the
peptides, was followed as a measure of their fuso-
w xgenic activity using a probe dilution assay 35,36 .
SUV labeled with fluorescent Pyr-PC were mixed
with unlabeled vesicles, and the excimer to monomer
intensity ratio of the pyrene probe was monitored as a
function of time. Vesicle fusion results in a decrease
of the excimer intensity and an increase of the
monomer intensity, due to dilution of the probe into
the fused vesicles. The overall decrease in the ErM
ratio as a result of fusion, is expressed as percentage
of the initial ErM value. As shown in Fig. 2A, the
 .PBP-A b 29–40 peptides was in a random confor-
mation when dissolved in aqueous buffer, and did not
induce any detectable lipid mixing. In contrast, solu-
 .bilizing the PBP-A b 29–40 peptide in 20% TFE
increased the fusogenic activity of the peptide, as
36% of lipid mixing was observed 30 min after
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Fig. 2. Influence of the peptide secondary structure and of the
PIP concentration on the rate of lipid mixing of PCrPErPIP2 2
 .SUV induced by 5 mM of PBP-A b 29–40 peptides. Aliquots of
 .PBP-A b 29–40 peptides were added to a mixture of labeled
SUV containing 2.5 mol% of Pyr-PC and of unlabeled SUV 42
.mM total phospholipids in a 10 mM Tris–HCl buffer pH 7.5,
containing 150 mM NaCl, 1 mM NaN , and 0.01 grl Na-EDTA.3
The Pyr-PC excimerrmonomer ratio was monitored at 258C and
 .is plotted as a percentage of the initial value vs. time. A
Peptides dissolved in a 10 mM Tris–HCl buffer containing 150
 .mM NaCl, 1 mM NaN , and 0.01 grl Na-EDTA ^ , in a3
 .mixture of buffer and TFE containing 20% TFE e , 50% TFE
 .  .‘ , or in pure TFE B were added to a mixture of labeled and
 .unlabeled PCrPE SUV containing 3 mol% PIP . B Peptides2
dissolved in 100% TFE were added to a mixture of labeled and
 .unlabeled PCrPE SUV v , PCrPE SUV containing 1.5 mol%
 .  .PIP ’ , and 3 mol% PIP B .2 2
addition of the peptide to SUV. Increasing the amount
of TFE in the buffer further increased lipid mixing,
 .up to 62% after 30 min when the PBP-A b 29–40
peptide was dissolved in pure TFE. As shown in Fig.
1, the a-helical content of the peptide is maximal in
100% TFE, suggesting that the fusogenic properties
 .of the PBP-A b 29–40 peptide increase when the
peptide is in a helical conformation. Peptides were
dissolved in 100% TFE in all subsequent experi-
ments.
3.4. Influence of the PIP concentration on the lipid2
mixing of PCrPErPIP ˝esicles induced by the2( )PBP-Ab 29–40 peptide
In order to determine the contribution of the spe-
cific PIP -binding of the PBP fragment to the fuso-2
 .genic activity of the PBP-A b 29–40 peptide, lipid
mixing experiments were performed with both
PCrPE SUV, and with PCrPE SUV containing 1.5
or 3 mol% PIP . Fig. 2B depicts the variation of the2
ErM ratio as a function of time, when 5 mM of
 .PBP-A b 29–40 peptide was added to a fixed amount
 .of SUV 42 mM of phospholipids . The PBP-
 .A b 29–40 peptide interacted with both PCrPE SUV
and PCrPE SUV containing PIP . The extent of lipid2
mixing was enhanced by the presence of increasing
amounts of PIP in the mixed vesicles. Indeed, the2
maximal decrease of the ErM ratio was around 60%
when 3 mol% PIP were incorporated in the vesicles,2
compared to only 30% at 1.5 mol% PIP , and 20%2
for SUV without PIP . In order to assess the increase2
 .of the fusogenic potential of the PBP-A b 29–40
peptide on PIP -containing SUV, we followed the2
extent and kinetics of lipid mixing as a function of
the peptide concentration. Using similar experimental
 .conditions, the activity of the A b 29–40 peptide
 .was compared to that of the PBP-A b 29–40 pep-
 .tide. Increasing amounts of PBP-A b 29–40 and
 .A b 29–40 peptides were added to a fixed amount
of SUV, and the decrease of the ErM ratio was
measured after 30 min incubation time. Control ex-
periments were performed with SUV and the PBP
peptide. All results are depicted in Fig. 3, where the
lipid mixing activity, expressed as the total percent-
age decrease in ErM ratio, is plotted as a function of
the peptide concentration. The change in the ErM
ratio as a function of time at increasing amounts of
 .  .the PBP-A b 29–40 , A b 29–40 , and PBP pep-
tides, shows that for all peptides tested, the extent of
lipid mixing is concentration-dependent. Significant
fusogenic activity was measured when the PBP-
 .A b 29–40 peptide was added to PCrPE SUV con-
 .taining 3 mol% of PIP Fig. 3A . The activity of the2
chimeric peptide was enhanced compared to that of
 .the A b 29–40 peptide, since 7.5 mM of this latter
were required to reach 30% of lipid mixing—i.e., at
approximately half the maximal lipid mixing capacity
of the peptides—compared to only 1.5 mM, i.e.,
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Fig. 3. Effect of the incorporation of PIP in PCrPE SUV on the2
 .  .  .  .  .activity of PBP-A b 29–40 B , A b 29–40 v and PBP ^
peptides. The activity of the different peptides was determined as
their ability to induce intervesicular lipid mixing. Aliquots of
peptides dissolved in 100% TFE were added to a mixture of
 .labeled and unlabeled A PCrPE SUV containing 3 mol% of
 .  .PIP , B PCrPE SUV containing 1.5 mol% of PIP , C and2 2
PCrPE SUV without PIP . The percentual decrease of the2
excimerrmonomer ratio, expressed as percent lipid mixing, after
 .30 min incubation at 258C of SUV 42 mM total phospholipids
and peptides, is reported as a function of the peptide concentra-
tion.
 .5-fold less, for the PBP-A b 29–40 peptide. In
agreement with the fusogenic activity measured for
 .the PBP-A b 29–40 peptide, the PBP peptide alone
had no significant effect in the concentration range
where maximal activity is observed with the PBP-
 .A b 29–40 peptide. Indeed, seven times more PBP
 .peptide 10 mM is needed to reach 30% of lipid
 .mixing when compared to PBP-A b 29–40 . Fig. 3A
shows that the PBP peptide is active in the same
 .concentration range as the A b 29–40 peptide. How-
 .ever, in contrast to the A b 29–40 peptide, the PBP
peptide is too hydrophilic to induce vesicle fusion.
The lipid destabilization properties of the PBP pep-
tide can therefore be attributed to specific interactions
occurring between the PBP peptides which are solu-
ble in aqueous buffer and SUV at high peptide
concentrations. Due to their high hydrophobicity, the
 .A b 29–40 peptides have a limited solubility in
aqueous solvent, thereby requiring high concentra-
tions to induce fusion. A two-fold decrease of the
PIP concentration in vesicles did not significantly2
 .affect either the fusogenic activity of A b 29–40 , or
the lipid destabilisation properties of the PBP peptide
 .Fig. 3B . In contrast the fusogenic advantage of
 .PBP-A b 29–40 peptide almost disappeared, as the
activity of this composite peptide became comparable
 .to that of the A b 29–40 peptide alone. The PBP-
 .A b 29–40 peptide showed a slightly increased ef-
fect compared to the PBP peptide, which can be
attributed to a residual fusogenic activity of the pep-
tide driven by specific PIP -peptide interactions, as2
this differential effect disappeared when PIP -free2
 .SUV were used Fig. 3C . It is noteworthy that the
 .lipid mixing effect of the A b 29–40 and PBP pep-
tides did not depend on the lipid composition of the
vesicles tested. Similar results were obtained with
 .LUV data not shown .
3.5. Effect of the charged phospholipid on the ˝esicu-
( )lar mixing induced by the PBP-Ab 29–40 peptide
Incorporation of PIP in SUV membranes signifi-2
cantly increased the fusogenic activity of the PBP-
 .A b 29–40 peptide. The specificity of the interac-
 .tions between PIP and the PBP-A b 29–40 peptide2
was investigated by comparing the efficiency towards
another negatively charged phospholipid, phos-
phatidylserine, PS, when incorporated into SUV
membranes. PS and PIP differ both by the number2
of negative charges in their polar headgroup and by
their molecular shape. The cross sectional area of the
two acyl chains of PS is similar to that of the polar
headgroup region, resulting in a cylindrical geometry
for this phospholipid. In contrast, PIP whose cross2
sectional area of the aliphatic chains is smaller than
that of the large bulky phosphoinositide polar head-
w xgroup, presents a conical shape 37 . Consequently,
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Fig. 4. Compared effect of PS on the activity of the PBP-
 .  .  .  .  .A b 29–40 B , A b 29–40 v and PBP ^ peptides. The
activity of the different peptides was determined as their ability
to induce intervesicular lipid mixing. Peptide aliquots dissolved
in 100% TFE were added to a mixture of labeled and unlabeled
 .  .PCrPErPS 18 mol% . The activity of the PBP-A b 29–40
 .peptide on PCrPErPIP 3 mol% SUV is shown for compari-2
 .son I, broken line . The percentual decrease of the
excimerrmonomer ratio, expressed as percent lipid mixing, after
 .30 min incubation at 258C, of SUV 42 mM total phospholipids
and peptides is plotted as a function of the peptide concentration.
due to the high curvature of SUV vesicles, the PIP2
molecules do not distribute symmetrically between
the internal and external leaflet of lipid bilayers such
as PS does. In mixed phosphatidylcholine SUV con-
taining 2.5 mol% PIP , 75% distributes to the outer2
w xlayer, the remainder goes to the inner layer 38 .
Moreover, PIP undergoes charge neutralization in2
the physiological pH range resulting in approximately
w xfour negative charges at pH 7.5 38 , while under
these conditions, PS contains one negative charge.
On the basis of these data, and in order to compare
the effect of an equal number of negative charges in
the external membrane leaflet, SUV were prepared
with 18 mol% PS, i.e., 9 mol% of negative charges in
the outer layer which is approximately the number of
charges present in the outer leaflet when using SUV
prepared with 3 mol% PIP . The effect of PS on the2
 .activity of the A b 29–40 and PBP peptides, was
also investigated under the same conditions. The
results of this comparative study are depicted in Fig.
4. When PCrPE SUV containing 18 mol% PS were
 .tested, the activity of the PBP-A b 29–40 peptide
was slightly increased as the concentration of the
 .PBP-A b 29–40 peptide inducing 30% lipid mixing
decreased by a factor 2. However, the high fusogenic
 .activity of the PBP-A b 29–40 peptide observed on
 .PCrPErPIP 3% vesicles at a three times lower2
concentration could not be obtained with PS charged
SUV. The presence of PS in SUV membranes did not
 .significantly affect the activities of the A b 29–40
and PBP peptides, which were similar to those ob-
served with PCrPE and PCrPErPIP SUV.2
( )3.6. Interaction of the PBP-Ab 29–40 and PBP
peptides with PCrPErPIP ˝esicles. Effect on the2
˝esicle size
 .The changes in the size of the PCrPErPIP 3%2
vesicles due to the events of fusion were monitored
Fig. 5. Effect of PIP on the gel filtration behavior of SUV in the2
 .  .absence and in the presence I-I of PBP-
 .  .  .  .A b 29–40 A and PBP B peptides. PBP-A b 29–40 and
PBP peptides dissolved in 100% TFE were added at a 5 mM final
 .concentration to 75 mM of PCrPErPIP 3 mol% SUV labeled2
with 2.5 mol% of Pyr-PC. After 15 min incubation in the
presence of the peptides, the mixture was applied to a Sepharose
CL-4B column, and the elution profile was recorded by monitor-
ing the Pyr-PC fluorescence emission at 398 nm. The localization
 .of the PBP-A b 29–40 and the PBP peptide in the chromato-
gram was determined by following the Tyrosine fluorescence
 .emission at 305 nm ’-’ . The void volume of the Sepharose
column corresponds to an elution volume of 12 ml.
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by size exclusion gel chromatography on a Sepharose
CL-4B column before and after mixing with the
 .PBP-A b 29–40 and PBP peptides, by following the
pyrene fluorescence monome of the labeled particles.
Fig. 5A shows that the homogenous population of
pyrene-labeled PCrPErPIP SUV containing 3 mol%2
PIP , incubated in the presence of 5 mM of the2
 .PBP-A b 29–40 peptides, is transformed into larger
particles eluting in the void volume of the column,
consistent with vesicle aggregation andror fusion.
Pyrene fluorescence intensity was maximal in the
 .void volume 12 ml . In the absence of peptides, the
labeled vesicles eluted at 21 ml. Direct monitoring of
the fluorescence emission of the tyrosine residues of
 .the PBP-A b 29–40 peptides was performed in par-
allel. As shown in Fig. 5A, the peptides eluted to-
gether with the fused vesicles, in the void volume of
the column. Control experiments carried out with 5
mM of the PBP peptide showed no significant change
in the vesicle size, consistent with the absence of
 .fusogenic activity of this peptide Fig. 5B . However,
in agreement with its lipid destabilisation properties
at higher concentration, the PBP peptide associated
with lipid vesicles, as it co-eluted with the lipids Fig.
.5B . Changes in the vesicular size could not be
detected at any concentration of the PBP peptide.
3.7. Core mixing of PCrPErPIP ˝esicles induced2( )by the PBP-Ab 29–40 peptides
In order to confirm the fusogenic properties of the
 .PBP-A b 29–40 peptides on PCrPE SUV contain-
ing 3 mol% of PIP , core-mixing experiments were2
carried out on two populations of PIP -containing2
SUV, labeled separately. Control experiments were
 .performed with the A b 29–40 peptide and with the
 .PBP peptide. When the A b 29–40 -PBP and
 .A b 29–40 peptides were added to a mixture of
calcein and Co2q- and of EDTA-containing SUV, an
increase of the calcein fluorescence was observed
 .data not shown . This fluorescence increase, due to
release of free calcein, might result from the EDTA–
Co2q complex formation. On the other hand, dilution
and subsequent dissociation of the calcein–Co2q
complex might also occur under leakage of the vesi-
cle content, resulting in an increase of the emission
intensity of free calcein. Fluorescence increase due to
leakage of vesicle contents was prevented by addition
 .Fig. 6. Core-mixing of PCrPErPIP 3 mol% SUV induced by2
 .  .  .  .  .PBP-A b 29–40 B , A b 29–40 v and PBP peptides ^ .
Peptides dissolved in 100% TFE were added to a mixture of
2q calcein and Co -, and of EDTA- containing SUV 1:1 molar
.ratio, 42 mM total phospholipids , in a 10 mM Tris–HCl pH 7.5
buffer, containing 150 mM NaCl, 1 mM NaN , and 0.4 mM3
Co2q chelated with 0.4 mM citrate. Core mixing of the two
populations of vesicles as described under Section 2, and the
percentage of the maximum calcein fluorescence after 30 min
incubation was plotted as a function of the peptide concentration.
One hundred percent of the calcein fluorescence was established
 .by lysing the vesicles with Triton X-100 0.5% wrv in the
presence of 10 mM EDTA.
2q of 0.4 mM Co chelated in a 1:1 molar ratio with
.citrate in the aqueous buffer. Fig. 6 illustrates the
effect of increasing concentrations of the PBP-
 .  .A b 29–40 and A b 29–40 peptides, on the core
mixing of calcein and Co2q- and of EDTA-contain-
ing SUV, after 30 min incubation in the presence of
Co2q in the aqueous phase. These results show that,
as previously demonstrated for the interaction of the
 .A b 29–40 peptide with PCrPE SUV, the PBP-
 .  .A b 29–40 and A b 29–40 peptides both induce
core mixing of the two populations of PCrPErPIP2
vesicles containing 3 mol% PIP . In agreement with2
the results of the lipid mixing assay, the PBP-
 .A b 29–40 peptide was active at lower concentra-
 .tions than the A b 29–40 peptide, since half maxi-
mal core mixing was observed at 1.5 mM with the
 .PBP-A b 29–40 peptide, a concentration where the
 .A b 29–40 peptide had no activity. Control experi-
ments demonstrated that the PBP peptide did not
induce core mixing of the two populations of vesi-
cles. Similar results were obtained with LUV data
.not shown .
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3.8. Leakage of PCrPErPIP ˝esicle contents in-2( )duced by the Ab 29–40 -PBP and PBP peptides
 .Previous results showed that the A b 29–40 pep-
tides did not only cause vesicle fusion, but also affect
w xthe permeability of the lipid vesicles 10 . This effect
 .was further investigated for the PBP-A b 29–40
peptides by following leakage of encapsulated calcein
from PCrPE SUV containing 3 mol% of PIP . The2
 .addition of the PBP-A b 29–40 peptides to these
SUV induced membrane destabilization as measured
by the calcein release from the vesicles. Fig. 7 illus-
trates the concentration-dependent release of calcein
from SUV, caused by the addition of the PBP-
 .  .A b 29–40 , A b 29–40 and PBP peptides. The
amount of calcein leakage induced by the three pep-
tides varied with the peptide concentration in the
same way as the lipid mixing measured with the
 .same PIP -containing vesicles. The PBP-A b 29–402
 .peptide was more active than A b 29–40 , inducing
100% calcein release at a 5 mM concentration com-
pared to an 8-fold higher concentration of A b 29–
.40 . Control experiments demonstrated that a 5 mM
concentration of PBP peptide induced only 5% cal-
cein release. These data then suggest that the PBP
 .Fig. 7. Leakage of calcein from PCrPErPIP 3 mol% SUV2
 .  .  .  .induced by PBP-A b 29–40 B , A b 29–40 v and PBP
 .^ peptides. Peptides were dissolved in 100% TFE, and peptide
 .aliquots were added to calcein SUV 42 mM total phospholipids
in a 10 mM Tris–HCl pH 7.5 buffer, containing 150 mM NaCl, 1
mM NaN , and 0.01 grl Na-EDTA. Calcein release from the3
vesicles was followed as described under Section 2, and calcein
release after 30 min of incubation with increased concentration of
peptides was plotted as a function of the peptide concentration.
One hundred percent of leakage was established by lysing the
 .vesicles with Triton X-100 0.5% wrv .
peptide neither contributes to vesicle fusion nor to
any changes in membrane properties of the lipid
vesicles. Similar results were obtained with LUV
 .data not shown .
4. Discussion
The purpose of this work was to design new
composite peptides with increased fusogenic effi-
ciency compared to that of natural hydrophobic fu-
sion peptides, whose solubility in aqueous buffers is
mostly limited. The chimeric peptide described here,
consists of the fusion peptide of the beta-amyloid
 . w xpeptide A b 10 , and of a positively-charged pep-
 .tide PBP which binds specifically to a negatively-
w xcharged phospholipid PIP 23,24 . The fusion pep-2
tide identified at residues 29–40 of the A b peptide
w xinvolved in the Alzheimer’s disease 15 , is referred
 .to as A b 29–40 . It was shown to induce vesicular
fusion with a concomitant alteration of the lipid
w xbilayer permeability 10 . PIP , a natural phospho-2
lipid present at less than 3 mol% in cellular mem-
branes, was reported to promote the membrane bind-
w xing of the A b peptide 22 . The targeting PIP -bind-2
ing peptide was therefore linked to the N-terminal
 .end of the A b 29–40 peptide in order to mimic the
positively charged N-terminal domain of the A b
w xpeptide 18 .
Our results show that specific membrane targeting
can significantly increase the fusogenic properties of
 .the A b 29–40 peptide. Indeed, the chimeric peptide
 .PBP-A b 29–40 promoted the fusion of PIP -con-2
taining SUV at significantly lower concentrations
 .than the A b 29–40 peptide. When 3 mol% PIP2
were added to the phospholipid vesicles, the mid-point
for maximal fusion was observed at a six-fold lower
 .concentration of the PBP-A b 29–40 peptide com-
 .pared to the A b 29–40 peptide. Fusion of SUV
vesicles was evidenced by the formation of larger
vesicular aggregates, significant intervesicular lipid
 .mixing and core mixing. In analogy to the A b 29–40
 .peptide, the PBP-A b 29–40 peptide was further
able to perturb the membrane bilayer, thus promoting
calcein release. Moreover, as observed for lipid mix-
ing, lower concentrations of the composite peptide
were required for calcein leakage compared to the
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 .A b 29–40 peptide. In agreement with the fusion
and leakage experiments, gel filtration of a mixture of
 .PIP -containing SUV and of the PBP-A b 29–402
peptide, confirmed the binding of the PBP-A b 29–
.40 peptides to fused vesicles. The hydrophilic PBP
peptide alone could not induce vesicle fusion, as
demonstrated by the absence of core mixing and
aggregation of vesicles. Lipid mixing and calcein
release were negligible at concentrations correspond-
ing to the optimal activity of the chimeric PBP-
 .A b 29–40 peptide, suggesting that the PBP peptide
has no direct effect on vesicle fusion. During lipid
mixing and calcein release experiments, changes in
the pyrene ErM ratio and leakage of vesicular con-
tents were observed at peptiderlipid molar ratios
above 1r4. The lipid destabilization properties of the
PBP peptide occurring at concentrations of this wa-
ter-soluble peptide around 15 mM, probably result
from non-specific interactions between the peptide
 .and SUV. Concentrations of the A b 29–40 peptide
similar to those of the PBP peptide were required for
membrane destabilization. However, the low aqueous
 .solubility of the hydrophobic A b 29–40 peptide
probably accounts for the high peptide concentrations
necessary to induce fusion.
The extent of fusion induced by the PBP-A b 29–
.40 peptide measured on SUV containing variable
amounts of PIP , decreased between 3 and 1.5 mol%2
PIP , and disappeared when PIP was not included in2 2
the vesicle preparation. This suggests that the absence
of ionic interactions between the peptide and the
charged lipids abolished the ability of the peptide to
disrupt lipid vesicles. The differences in the fuso-
 .genic activity of the PBP-A b 29–40 peptides on
vesicles containing variable amounts of PIP , was not2
due to a higher stability of the vesicles with de-
creased charge. All SUV preparations had similar
diameters, as estimated from gel filtration experi-
 .ments. Moreover, the neutral A b 29–40 peptides
had comparable fusogenic activity on charged and on
neutral vesicles, consistent with a similar internal
strain and overall stability of the vesicles. The pres-
ence of PIP in PCrPE vesicles did not affect the2
lipid mixing activity of the PBP peptides, in agree-
ment with a non-specific effect of these peptides and
with comparable stability of the lipid vesicles.
Fusion of PIP -containing SUV induced by the2
 .PBP-A b 29–40 peptide results from the insertion of
the fusogenic peptide into the lipid bilayer. This
occurred only after ionic interactions between the
positively-charged PBP peptide and the PIP -negative2
headgroups, suggesting that peptide-targeting en-
hances the fusogenic activity of the peptide. Our data
moreover suggest that, although the presence of PIP2
target sites on the membrane surface is required, it is
not sufficient to promote vesicular fusion. The mem-
brane destabilization properties of the PBP-A b 29–
.40 peptides are further dependent upon the sec-
ondary structure of the peptides. CD measurements
show that, when the peptides are dissolved at increas-
ing concentrations of a strong helix-promoting sol-
vent such as TFE, they undergo a coil to a-helix
a-transition. This is accompanied by a significant
increase of the fusogenic activity of the peptides on
SUV. In most studies on viral fusion proteins, an
a-helical structure has been suggested to represent
the fusion active conformation of lipid-bound pep-
w xtides 9,14,39–42 , although other studies suggest
that peptides in a b-sheet conformation could also be
w xfusogenic 43,44 . The entire A b peptide for exam-
ple was shown by circular dichroism to adopt mostly
a b-sheet conformation, when located in a lipid
w xenvironment 18,22 . These apparent discrepancies
might be related to differences between assays used
to quantify peptide–lipid interaction. Structural mea-
surements for example are performed under equilib-
rium conditions, after fusion is complete. This does
not exclude the possibility that an a-helical confor-
mation of the peptide is involved in the first stage of
the fusion process, prior to the formation and stabi-
lization of b-sheet structures through hydrophobic
interactions with the core of the lipid bilayer. Compa-
rable peptide concentrations of either PBP-A b 29–
.  .40 or A b 29–40 are required for vesicular fusion
and for calcein release on PIP -containing PCrPE2
SUV. This observation supports the hypothesis that,
membrane fusion involving insertion of the peptides
under an a-helical form into the lipid membrane
might be followed by peptide self-association within
the lipid phase. This would result in the formation of
holes in the lipid membrane and leakage of liposomal
w xcontents. Brasseur et al. 7,8 proposed that fusogenic
peptides behave as oblique-orientated helices trigger-
ing membrane fusion. Such helices are characterized
by an asymmetric distribution of the bulky hydropho-
w xbic residues along the axis of the peptide 7 . The
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more hydrophobic extremity of the helix inserts into
the lipid membrane at an oblique angle with respect
w xto the lipid–water interface 9,14 , thus inducing a
w xlocal disorganisation of the bilayer structure 12,45 .
It had been previously described that actin binding
of either villin or fragmin containing the PIP -binding2
PBP peptide, cannot be completely inhibited by other
negatively charged phospholipids such as phos-
w xphatidylserine 23,27 . Liposomal membranes con-
taining enough PS to ensure an equal number of
negative charges in the outer layer could not restore
the high fusogenic efficiency observed with PIP .2
 .The activity of the PBP-A b 29–40 peptide on
PIP -containing vesicles was three-fold higher than2
on PS-containing SUV. This difference might be
related to the topology of the negative charges in the
membrane. The cylindrical shape of phosphatidylser-
ine, presenting one net negative charge at physio-
logical pH, forms a steric barrier, preventing a close
proximity of two negatively charged phospholipid
headgroups. As a result, the formation of small clus-
ters of negative charges in PS-enriched membranes,
 .is not favourable at low molar PSr PCqPE ratios.
Thus, clusters of negative charges in lipid mem-
branes, as those displayed by one highly charged PIP2
molecule, probably favor stronger electrostatic
lipid–peptide interactions. The binding of PIP to the2
PBP sequence in actin-binding proteins was at-
tributed to the particular lysine-rich sequence KXKK
w x23 . Arg and Lys residues might both contribute to
 .the electrostatic interaction of the A b 29–40 -PBP
peptides with negatively-charged vesicles. However,
clusters of negative charges as those displayed by one
PIP molecule might favor stronger interactions with2
Lys residues that are close neighbours in the peptide
sequence. This hypothesis is supported by data show-
ing respectively higher and lower efficiency of PIP3
and PIP for the binding of a PIP -binding domain2
w xidentified in the N-terminal region of ezrin 46 . As
the lysine «-NH group has a unique flexibility, this2
amino acid residue might match more closely the
acidic headgroups of PIP , and thereby promote a2
strong association with PIP .2
In conclusion, our results demonstrate that, both
 .the ability of the A b 29–40 amyloid peptide to
induce fusion and alter the membrane permeability of
vesicles, and that of the PBP peptide to bind specifi-
cally to PIP , are conserved within the chimeric2
 .PBP-A b 29–40 peptide. In addition to the require-
ment for an a-helical conformation, the presence of
PIP lipid targets was found essential for optimal2
 .fusogenic activity of the PBP-A b 29–40 peptide.
This suggests that the fusion process is initiated by an
interaction between the PBP moiety and the PIP2
headgroups, followed by the insertion of the peptide
in the lipid phase. It is obvious that this composite
peptide can only mimic the complex fusogenic prop-
erties of a viral protein to a limited extent. Neverthe-
less, the properties of the peptide that were identified
as critical in the present study, such as specific
membrane binding, helical secondary structure and
membrane destabilisation were also proposed as re-
wquirements for fusion induced by viral proteins 9–
x11,14,36 , and could be applied to the design of other
chimeric fusogenic peptides.
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